Hepatocellular carcinoma in 2014: current situation and future prospects

Area of Science:

• Hepatology
• Oncology
• Public Health

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern, with chronic liver disease as its primary driver.
• Key etiologies globally include hepatitis B and C viruses, while alcohol and non-alcoholic steatohepatitis (NASH) are prominent in France.
• Recent trends in France indicate a potential deceleration in HCC incidence and a decline in mortality rates.

Purpose of the Study:

• To analyze the current trends and challenges in hepatocellular carcinoma (HCC) management.
• To evaluate the effectiveness of current screening protocols for HCC.
• To identify factors limiting the efficacy of HCC screening in developed nations.

Main Methods:

• Review of epidemiological data on HCC incidence and mortality in France.
• Analysis of current screening practices, including liver ultrasound and alpha-fetoprotein assays.
• Assessment of adherence to clinical guidelines for HCC screening in patients with chronic liver disease.

Main Results:

• The incidence of HCC, after decades of increase in France, shows signs of slowing.
• Mortality rates associated with HCC appear to be decreasing.
• Serum alpha-fetoprotein assays are deemed ineffective for HCC screening; liver ultrasound every six months is standard.
• Failure to diagnose cirrhosis and poor adherence to guidelines significantly undermine screening effectiveness.

Conclusions:

• Despite a potential slowdown in HCC incidence and falling death rates, significant challenges remain in optimizing screening.
• Accurate identification of patients with cirrhosis is crucial for effective HCC surveillance.
• Adherence to established clinical guidelines is essential to maximize the benefits of HCC screening programs.